A new study found difamilast ointment 1% to be safe and efficacious in the treatment of atopic dermatitis (AD).
Psoriasis patients with and without psoriatic arthritis self-report higher analgesic use
According to a new study, psoriasis patients, with and without psoriatic arthritis (PsA), self-report using analgesics more than those without the disease. This may be due to increased joint pain.
Ustekinumab less effective for psoriasis in lower extremities, according to study
A new study has shown that clinical response in psoriasis patients treated with ustekinumab tends to vary by anatomical region, with the lower extremities seeing the least response.
Dupilumab-induced ocular surface disease more frequently associated with AD, study shows
According to a new study, dupilumab-induced ocular surface disease (DIOSD) appears to occur more frequently in patients with atopic dermatitis (AD) than in patients with other conditions being treated with the biologic.
University of Toronto establishes Chair in Ethnodermatology position
The University of Toronto has just established the AbbVie Chair in Ethnodermatology, one of the first positions of its kind, to support diversity in dermatology training, research and care, according to a press release.
Study shows early response to biologics linked to stable long-term efficacy in psoriasis
Findings from a new study has shown that early response to ixekizumab and ustekinumab is associated with maintaining stable long-term skin clearance in patients with moderate-to-severe psoriasis.
Self-help interventions help reduce shame and improve QOL in psoriasis patients, study shows
According to a new study, some psoriasis patients may experience a reduction in shame and improvement in quality of life (QOL) after exposure to self-help interventions.
Researchers review HS biomarkers and criteria for validation in clinical trials
Researchers have reviewed the literature on biomarkers for hidradenitis suppurativa (HS) to evaluate the validity of these biomarkers and to identify the reasons for their lack of use in clinical trials.
Psoriasis patients experience vaccine hesitancy and treatment disruptions during pandemic
A new study evaluates vaccine hesitancy and medication changes in psoriasis patients during the Covid-19 pandemic.
Dupilumab reduces hospitalizations in patients with AD, according to new study
According to a new study, adult patients with moderate-to-severe atopic dermatitis (AD) being treated with dupilumab had lower rates of hospitalization and shorter stays when compared to those not on dupilumab.
HealthMinute.TV 